SCHEMBL7557902

SCHEMBL7557902

CC(CN(C)C)n1cc(-c2cncc(-c3ccccc3)c2)c2ccc(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.46
FLT1 P17948 2/20 0.46
FLT4 P35916 2/20 0.46
MAT2A P31153 5/20 0.35
NFATC1 O95644 1/20 0.34
GSK3B P49841 1/20 0.34
DYRK1A Q13627 1/20 0.34
CNR1 P21554 1/20 0.34
HTR6 P50406 1/20 0.34
CHRM1 P11229 1/20 0.34
SLC2A1 P11166 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
MAOA P21397 1/20 0.33
PRMT5 O14744 2/20 0.32
MDM4 O15151 1/20 0.32
TP53 P04637 1/20 0.32
MDM2 Q00987 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976277 0.94 KDR (0.43) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7988607 0.93 KDR (0.43) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7548512 0.92 KDR (0.43) KDRFLT1FLT4MAT2ACNR1
SCHEMBL7552885 0.88 KDR (0.51) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7990418 0.88 KDR (0.39) KDRFLT1FLT4MAT2AADORA3
SCHEMBL7549779 0.88 KDR (0.54) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7549609 0.87 KDR (0.49) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7547648 0.86 KDR (0.58) KDRFLT1FLT4NFATC1GSK3B
SCHEMBL7994139 0.84 KDR (0.41) KDRFLT1FLT4MAT2A
SCHEMBL7990966 0.84 KDR (0.63) KDRFLT1FLT4MAT2ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed